Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Titan Pharmaceuticals To Present At Cantor Fitzgerald Global Healthcare Conference | ||
By: PR Newswire Association LLC. - 20 Sep 2017 | Back to overview list |
|
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2017 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, announced today that Titan President and CEO Sunil Bhonsle will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, Sept. 27 at 9:45 a.m. EDT at the Intercontinental New York Barclay Hotel. Mr. Bhonsle will review the company's ProNeura-based pipeline of clinical and early-stage product candidates, as well as provide a market update on Probuphine for the maintenance treatment of opioid dependence. The presentation will be available as a live and archived webcast on the Events page on Titan's website. About Titan Pharmaceuticals This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to the commercialization of Probuphine, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. CONTACT: Titan Pharmaceuticals, Inc.: Investors: Media:
View original content with multimedia:http://www.prnewswire.com/news-releases/titan-pharmaceuticals-to-present-at-cantor-fitzgerald-global-healthcare-conference-300523229.html SOURCE Titan Pharmaceuticals, Inc. |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |